Mr. Gabriel Fahel reports

CYBIN ANNOUNCES DATE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS

Cybin Inc.'s 2023 annual and special meeting of shareholders will be held virtually on Thursday, Oct. 12, 2023, at 1 p.m. ET.

The notice of annual and special meeting and proxy statement containing meeting details are available under the company's profile on SEDAR+, and on the company's website, and are expected to be mailed on Sept. 21, 2023, to shareholders of record as of the close of business on Aug. 30, 2023.

About Cybin Inc.

Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions.

We seek Safe Harbor.